CJC-1295 (DAC) 10 MG

CJC-1295 (DAC) is a synthetic peptide derivative structurally related to growth hormone-releasing hormone (GHRH). It has been developed as a stabilized analog with a Drug Affinity Complex (DAC) to extend its half-life for research purposes and is primarily studied in laboratory settings for its potential effects on growth hormone secretion, metabolism, and peptide pharmacology. Preclinical studies have investigated CJC-1295 (DAC) in relation to experimental models of growth hormone regulation, muscle growth, and metabolic function.

Research involving CJC-1295 (DAC) commonly explores:

• Its role in stimulating pulsatile release of growth hormone and insulin-like growth factor 1 (IGF-1) in cellular and animal models.
• Possible contributions to muscle growth, fat metabolism, and recovery in endocrine and metabolic research systems.
• Experimental assessment of its prolonged activity and pharmacokinetics due to the DAC modification.
• Its activity in studies of aging, metabolic disorders, and tissue repair, where its stability and molecular design are key topics of interest.
CJC-1295 (DAC) is provided as a lyophilized powder for laboratory research use only (RUO). It is not intended for diagnostic, therapeutic, or clinical applications and must not be used in humans or animals.

Product details:

• Synonyms: CJC-1295 with Drug Affinity Complex, Modified GHRH analog
• Purity: ≥98%
• CAS Number: 863288-34-0
• Molecular Formula: C172H265N47O51
• Molecular Weight: Approximately 3047.0 Da
• Appearance: White to off-white lyophilized powder

This product is intended exclusively for scientific research and laboratory investigation in compliance with applicable regulatory guidelines.